Analyst Ratings for GreenLight Biosciences (GRNA)

GRNA Rating Summary

  |   Expand Research on GRNA
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 0 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/31/2023 Canaccord Bobby Burleson Downgrade Hold
(Buy)
0.30
(4.00)
0.29
(0.30)
3.45% Details
4/3/2023 Credit Suisse John Roberts Downgrade Neutral
(Outperform)
0.60
(5.50)
0.43
(0.30)
-30.23% Details